About Horizon Discovery

Horizon Discovery, formerly of PerkinElmer, and now part of the Revvity family, drives the application of gene editing and gene modulation to enable world-leading academic institutes, pharmaceutical and biotechnology companies, as well as clinical diagnostic laboratories, to identify the genetic drivers behind human disease, develop and validate diagnostic workflows, and deliver new therapies for precision medicine.

With more than a decade of experience in the engineering of cell lines, Horizon offers innovative tools and services based upon the ability to modulate, or permanently alter, the function of almost any gene in human and other mammalian cell lines.

Horizon is headquartered in Cambridge, UK with offices in USA and Japan.

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Location
8100 Cambridge Research Park, Waterbeach, Cambridge, Cambridgeshire CB25 9TL, GB
description icon
Founded
2005
description icon
Keywords
Rna, Molecular Diagnostics, Sirna, Crispr, Mirna, Gene Editing, Cell Based Assays, Cell Line Engineering, Cell Lines, Shrna, Bioproduction Cell Lines, Crispr Reagents, Crispra, Crispri, Custom Rna Synthesis, Edited Cho Cells, Functional Genomic Screening, Gene Modulation, Reference Standards, T Cell Screening, Noncoding Rna

Horizon Discovery Alternatives

Industry
Biotechnology
Industry
Biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology

Frequently Asked Questions about Horizon Discovery

Who are the decision makers in Horizon Discovery?

The decision makers in Horizon Discovery are Anna Copping, Dennis France, Jesus Zurdo, etc. Click to Find Horizon Discovery decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more